Search results

| group1 = Specific [[reuptake]] [[Reuptake inhibitor|inhibitor]]s (RIs), [[Reuptake enhancer|enhancer]]s (REs), and [[Releasing agent|rele ...mall>[[Selective serotonin reuptake inhibitor|Selective serotonin reuptake inhibitor]]s (SSRIs)</small>

| group6 = [[Phosphodiesterase inhibitor]]s ''[[1,3-Indandione]]s:'' [[Clorindione]]{{•}} [[Diphenadione]]{{•}} [[Phenindio

| group2 = [[Phosphodiesterase inhibitor]]s | list3 = ''[[5-HT3 antagonist|5-HT₃ antagonists]]'' ([[Alosetron]], [[Cilansetron]]){{·}} ''[[Serotonin

| name = Phosphodiesterase inhibitors | title = [[Phosphodiesterase inhibitor]]s ([[ATC_code_C01#C01CE_Phosphodiesterase_inhibitors|C01CE]], [[ATC_code_G

| IUPAC_name = 3,7-dimethyl-1-(5-oxohexyl)-3,7-dihydro-1''H''-purine-2,6-dione | C=13 | H=18 | N=4 | O=3

{| border="border" cellpadding=3 style="border-collapse:collapse" | [[21-hydroxylase deficiency]] || || 6p21.3

In pyrimidine metabolism, EC 3.6.1.2 (trimetaphosphatase) can convert trimetaphosphate into triphosphate p ...estis |journal=Histol Histopathol. |year=1995 |month=Jul |volume=10 |issue=3 |pages=681–9 |pmid=7579818 }}</ref>

[[PDE5 inhibitor]]s and [[potassium channel opener]]s can also have similar results. ...h |publisher=Elsevier/Saunders |location= |year= |pages= |isbn=1-4160-2328-3 |oclc= |doi=}} Page 479</ref>

...l. Severed PHTN in liver Transplant candidates. Liver Transplant Surg 1997 3:494</ref> The survival of those with cirrhosis is sharply curtailed by PPH ...ransplant patients with pulmonary hypertension. Liver Transplant Surg 1997:3:454-55</ref><ref name=Kim>Kim et al. Accuracy of Doppler Echos in the asses